Kingdon Capital Management’s Zimmer Biomet ZBH Stock Holding History

Kingdon Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-96,543	Closed	-$11M	–	81
2019 Q2	$11M	Buy	96,543 +28,795	+43%	+$3.37M	1.08%	31
2019 Q1	$8.4M	Buy	67,748 +798	+1%	+$90.7K	1.12%	33
2018 Q4	$6.74M	Buy	+66,950	New	+$7.53M	1.02%	38
2014 Q1	–	Sell	-25,029	Closed	-$2.27M	–	213
2013 Q4	$2.27M	Buy	+25,029	New	+$2.17M	0.1%	156

Other funds holding ZBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Kingdon Capital Management's ZBH Position: Q3 2019 in Review

Kingdon Capital Management sold out of Zimmer Biomet (ZBH) in Q3 2019, closing a stake of 96,543 shares — an estimated $11M sold.

Kingdon Capital Management first reported a position in ZBH in Q4 2013 and held it in 4 quarters. The position peaked at $11M in Q2 2019. 897 funds tracked by Wall St. Rank hold ZBH as of Q3 2019.

Kingdon Capital Management reported no remaining Zimmer Biomet position as of Q3 2019 after selling out during the quarter.
Kingdon Capital Management sold 96,543 Zimmer Biomet shares in Q3 2019, an estimated $11M.
Kingdon Capital Management first reported a position in Zimmer Biomet in Q4 2013 and held it in 4 quarters.
Kingdon Capital Management's Zimmer Biomet position peaked at $11M in Q2 2019.
897 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2019.

Based on Kingdon Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.